INFU: the cashflow

MyFinsight

The latest financial statement is for the quarter ending 2025-09-30.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Cash Flow	2025-09-30	2025-06-30
Net income	2,259	2,332
Provision for doubtful accounts	63	39
Depreciation	3,070	6,166
Loss on disposal of and reserve adjustments for medical equipment	-43	380
Gain on sale of medical equipment	559	1,723
Amortization of intangible assets	214	495
Amortization of deferred debt issuance costs	22	39
Stock-based compensation	1,322	1,769
Deferred income taxes	1,167	1,363
Accounts receivable	78	2,089
Inventories	-78	-863
Other current assets	786	-24
Other assets	78	-1,106
Accounts payable and other liabilities	1,842	-1,975
Net cash provided by operating activities	8,493	8,789
Acquisition of business	0	1,412
Purchase of medical equipment	1,027	4,314
Purchase of property and equipment	79	348
Proceeds from sale of medical equipment, property and equipment	854	1,728
Net cash used in investing activities	-252	-4,346
Principal payments on long-term debt	14,004	30,261
Cash proceeds from long-term debt	8,785	32,717
Debt issuance costs	218	12
Common stock repurchased as part of share repurchase program	2,168	6,395
Common stock repurchased to satisfy statutory withholding on employee stock-based compensation plans	578	458
Cash proceeds from exercise of options and espp	177	159
Net cash used in financing activities	-8,006	-4,250
Net change in cash and cash equivalents	235	193
Cash and cash equivalents at beginning of period	527	-
Cash and cash equivalents at end of period	955	-

Unit: Thousand (K) dollars